Editorial Board: Journal of Neurosurgery

Editor-in Chief
James Rutka

Co-Chairs
Louis Kim (5/17 – 5/23)
Sepideh Amin-Hanjani (5/18 – 5/23)
Lynda Yang (5/18 – 5/23)
John A. Jane Jr. (5/18 – 5/23)
Mark Hamilton (5/18 – 5/23)

Editorial Board
Justin F. Fraser (6/18 – 5/24)
Rose Du (5/19 – 5/24)
Judy Huang (5/19 – 5/24)
Anthony M. Kaufmann (5/19 – 5/24)
Gabriel Zada (5/19 – 5/24)
Manish Aghi (1/20 – 5/25)
Andrew Carlson (1/20 – 5/25)
Elizabeth B. Claus (1/20 – 5/25)
William Mack (1/20 – 5/25)
Daniel M. Prevedello (1/20 – 5/25)
Bernard R. Bendok (5/21 – 5/26)

Kate Drummond (5/21 – 5/26)
Constantinos Hadjipanayis (5/21 – 5/26)
David Hasan (5/21 – 5/26)
Peter Kan (5/21 – 5/26)
Nader Sanai (5/21 – 5/26)
Alon Mogilner (5/22 – 5/26)
Dario J. Englot (5/22 – 5/26)
Ian F. Parney (5/22 – 5/26)
Juan Fernandez-Miranda (5/22 – 5/26)
Michael Lim (5/22 – 5/26)
Phil Taussky (5/22 – 5/26)
Stacey Quintero Wolfe (5/22 – 5/26)
Sunit Das (5/22 – 5/26)

 

Editorial Boards members are selected by a vote undertaken by standing members of each journal’s Editorial Board. Members serve approximately 5 years, advancing to the position of Co-Chair in their final year. Editorial Board members usually review 100+ manuscripts per year; this number increases to nearly 300 manuscripts during their final year as Co-Chair.


Louis Kim

Dr. Louis J. Kim is currently Professor and Vice-Chair in the Department of Neurological Surgery at the University of Washington School of Medicine. He is also the Chief of Neurological Surgery at Harborview Medical Center and Associate Residency Program Director. He completed his undergraduate degree summa cum laude at Middlebury College, where he was elected to the Phi Beta Kappa Honor Society. He earned his medical degree at Columbia University College of Physicians & Surgeons with Alpha Omega Alpha honors. Under the tutelage of Drs. Robert Spetzler and Volker Sonntag, Dr. Kim completed his neurosurgery residency and fellowship training in both cerebrovascular/skull base and endovascular neurosurgery at Barrow Neurological Institute. After his clinical training, he joined the Department of Neurological Surgery at the University of Washington School of Medicine in Seattle under the mentorship of Richard Ellenbogen.

Dr. Kim’s clinical practice specializes in the microsurgical and endovascular treatment of aneurysms, AVMs, dural AV fistulas, cavernous malformations, moyamoya disease, and skull base tumors. He is passionate about translational research, including next-generation sequencing of cerebrovascular tissue in pursuit of the pathogenesis of brain aneurysms and AVMs; computation fluid dynamics modeling to predict the efficacy of aneurysm treatment; and novel clinical imaging techniques for cerebral vasospasm, moyamoya disease, and vasculitis. Dr. Kim’s research has been funded with grants from the FDA, Department of Defense, Washington Research Foundation, and NIH, including a recently awarded R01 from the NIH/NINDS.

Dr. Kim holds several patents and pending patents pertaining to surgical robotics and minimally invasive endoscopic neurosurgery. He is also co-founder of Spi Surgical, Inc., a medical device and surgical robotics start-up. Part of this work led to the development and subsequent FDA approval of an endonasal pathway protection device known as Spiway, which is in clinical use today.

Dr. Kim has published over 100 peer-reviewed articles in the areas of cerebral aneurysms, AVMs, dural AV fistulas, cavernous malformations, and complex microsurgical and endovascular technique. He has written numerous book chapters and editorials. He has been an invited lecturer and teacher throughout North and South America, Asia, and Europe. Dr. Kim was elected to the Editorial Board of Journal of Neurosurgery in 2017.

 

Sepideh Amin-Hanjani

Dr. Sepideh Amin-Hanjani received her medical degree at Harvard Medical School and completed neurosurgery residency training at the Massachusetts General Hospital in Boston, Massachusetts, followed by a Cerebrovascular and Skull Base fellowship at the Barrow Neurological Institute in Phoenix, Arizona. She was tenured Professor and Residency Program Director in the Department of Neurosurgery at the University of Illinois at Chicago until 2022, where she served as Co-Director of Neurovascular Surgery, with clinical work focused on treatment of cerebrovascular disease. She is currently Professor of Neurosurgery and Vice Chair in the Department of Neurosurgery at University Hospitals/Case Western Reserve University, and serves also as Director of Cerebrovascular and Skull Base Surgery. Her longstanding research interests lie in the area of cerebrovascular blood flow and stroke, and she has held NIH funding as PI for a multi-site international study of blood flow in vertebrobasilar disease. Dr Amin-Hanjani is active in national organizations and is currently Treasurer of the AANS, and Vice Chair of the AHA/ASA Stroke Council.

She has previously served as Chair of the AANS/CNS Cerebrovascular Section, and as a Member at Large of the CNS Executive Committee. Dr Amin-Hanjani became a Diplomate of the American Board of Neurological Surgery in 2004; she is also an elected member of the Society of Neurological Surgeons, the American Academy of Neurological Surgery and Society of University Neurosurgeons, a Fellow of the American Heart Association and American College of Surgeons, and serves as a Medical Advisory Board Regional Co-Director for the Brain Aneurysm Foundation. She has authored over 150 publications and 25 book chapters, and she participates in editorial review for multiple journals.

Dr. Amin-Hanjani was elected to the Editorial Board of the Journal of Neurosurgery in 2018.

 

Lynda Yang

Dr. Lynda Yang received her medical research training through the NIH-Medical Scientist Training Program at the Johns Hopkins School of Medicine. She received her neurosurgery training from the University of Michigan and completed further peripheral nerve and brachial plexus surgery training with Dr. David Kline (LSU), Dr. Rolfe M. Birch (Orthopedics, Royal National Orthopedic Trust, UK), and Dr. Martijn Malessy (Neurosurgery, Leiden University Medical Center, NL). Dr. Yang’s research interests currently involve the furthering of evidence-based practice in peripheral nerve and brachial plexus surgery.

Dr. Yang is currently Professor in the Department of Neurosurgery and Director of the Brachial Plexus and Peripheral Nerve Program at the University of Michigan. She has served as Chairperson for the AANS/CNS Peripheral Nerve Division and in the organizational leadership in national and international peripheral nerve societies. She serves as member and/or past-chairperson on the Neurological Devices Advisory Panel in the Center for Devices and Radiological Health of the FDA.

Dr. Yang was elected to the Editorial Board of the Journal of Neurosurgery in 2018.

 

John A. Jane Jr.

Dr. John A. Jane Jr. is currently Professor of Neurosurgery and Pediatrics; Director of Pediatric Neurosurgery; Director of the Neuroendocrine Program; and Director of the Neurosurgery Residency Training Program at the University of Virginia. He received his B.A. at the University of Chicago, where he graduated with honors in 1992. He attended medical school at the University of Virginia, where he also completed his neurosurgical residency in 1997. After spending a year as a Fellow in Neurosurgery at Auckland Hospital in Auckland, New Zealand, he returned to UVA to finish his chief year in neurosurgery in 2003 with John A. Jane Sr. He then completed a pediatric neurosurgery fellowship, acting as the Chief Fellow of Pediatric Neurosurgery, at the Hospital for Sick Children in Toronto with Dr. James M. Drake.

In 2004 Dr. Jane Jr. joined the faculty at the University of Virginia as Assistant Professor and was named Director of the Division of Pediatric Neurosurgery, a practice that he shared with his father, John A. Jane Sr. In 2007, he was named Co-Director of the Neuroendocrine Program. He was promoted to Associate Professor in 2008, attained tenure in 2012, and became Professor in 2015. He became Director of the Neurosurgery residency training program in 2014.

In addition to his pediatric practice, Dr. Jane has a strong clinical and academic interest in the treatment of patients with pituitary and parasellar tumors, an interest that began under the tutelage of Dr. Edward R. Laws Jr. and continued with his colleague Dr. Edward H. Oldfield. He is an author of over 130 peer-reviewed publications on a variety of topics, including pituitary adenomas, craniopharyngiomas, craniosynostosis, Chiari malformations, hydrocephalus, and neurosurgical education and training.

Dr. Jane Jr. was elected to the Editorial Board of the Journal of Neurosurgery in 2018.

 

Mark Hamilton

Dr. Mark Hamilton obtained his Bachelor of Science degree (with distinction) at the University of Toronto and then graduated from McGill University Medical School in 1983. He did his Neurosurgery Residency at the University of Calgary and received his FRCSC in 1991. He did fellowship training in cerebrovascular, skull base and pediatric neurosurgery at the Barrow Neurological Institute in Phoenix, Arizona, and joined the University of Calgary Department of Clinical Neurosciences in 1994, where he is currently a Professor of Neurosurgery with additional appointments in the Department of Surgery and the Department of Pediatrics. He was the Chief of the Division of Pediatric Neurosurgery from 2002 to 2011. He is head of the University of Calgary Adult Hydrocephalus Program, which he established, along with the University of Calgary Adult Hydrocephalus Clinic, in 2008. Dr. Hamilton is the chair of the Adult Hydrocephalus Clinical Research Network (AHCRN), which has eight clinical sites in three countries; President-Elect of the Hydrocephalus Society (International Society for Hydrocephalus and Cerebrospinal Fluid Disorders [ISHCSF]); and a member of the Board of Directors of the Hydrocephalus Association (HA) and the Medical Advisory Board (MAB) of the HA, as well a member of the Board of Directors of Hydrocephalus Canada. His current main clinical and research interests are the diagnosis and management of hydrocephalus in adults.

Dr. Hamilton was elected to the Editorial Board of the Journal of Neurosurgery in 2018.

 

Justin F. Fraser

Dr. Fraser graduated from Princeton University with a degree from the Woodrow Wilson School of Public and International Affairs. His Princeton thesis discussed the American healthcare system, focusing upon the effect of managed care on the physician-patient relationship. He obtained his medical degree from the Weill Medical College of Cornell University. He completed residency in neurological surgery at Weill Cornell Medical College, where he also completed a fellowship in endovascular neurosurgery/interventional neuroradiology. He is currently Associate Professor and Director of Cerebrovascular Surgery in the Department of Neurological Surgery at University of Kentucky, where he specializes in cerebrovascular, endovascular, skull base, and endoscopic transsphenoidal surgery. As Surgical Director of the University of Kentucky Comprehensive Stroke Center, he focuses on treating stroke, carotid stenosis, intracranial aneurysms, arteriovenous malformation, pituitary tumors, and other skull base tumors. His academic research focuses upon the further advancement of the neuroprotective therapies for acute ischemic stroke. He has been Principal Investigator on several investigator-initiated clinical studies (eg. SAVER-I, STABILISER, MAVARIC), as well as a site-PI for multiple industry-led clinical trials. In the UK Center for Advanced Translational Stroke Science, Dr. Fraser leads a research team that has built an ongoing tissue bank for evaluating molecular and cellular changes in acute stroke patients.

Dr. Fraser was elected to the Editorial Board of Journal of Neurosurgery in 2018.

 

Rose Du, MD

Rose Du, MD, PhD, is Professor of Neurosurgery and Director of Cerebrovascular Surgery at Brigham and Women’s Hospital/Harvard Medical School. She received her BA (summa cum laude) in physics from Harvard University. She subsequently entered Harvard Medical School’s MD/PhD program and received her PhD in physics from the Massachusetts Institute of Technology, where she studied protein folding. She completed her internship and residency at the University of California at San Francisco, after which she undertook a cerebrovascular fellowship with Dr. Arthur Day at the Brigham and Women’s Hospital. She subsequently joined the faculty at the Brigham and Women’s Hospital.

Dr. Du’s research interests include the genetics of stroke and cerebral aneurysms, as well as other cerebrovascular diseases. Her research has been funded by the National Institutes of Health, as well as by several private foundations. She has more than 150 scientific publications and currently serves on the editorial boards of Neurosurgery, Stroke, and Translational Stroke Research. Dr. Du was elected to the editorial board of the Journal of Neurosurgery in 2019.

 

Judy Huang, MD

Dr. Judy Huang is Professor and Vice Chair of Neurosurgery at the Johns Hopkins University School of Medicine. In addition, she serves as Director of the Neurosurgery Residency Program and Director of the Cerebrovascular Surgery Fellowship.

After graduating magna cum laude from Brown University, she received her MD from the Columbia University College of Physicians & Surgeons. Her neurosurgery residency training was completed at the Neurological Institute of New York.

Dr. Huang’s clinical and research interests are devoted primarily to arteriovenous malformations, aneurysms, and ischemic and hemorrhagic stroke. She has won awards for excellence in teaching and clinical care. She has authored numerous peer-reviewed publications and book chapters and serves on the editorial board of Neurosurgery. Dr. Huang is often invited to lecture at international and national conferences. She has served on several committees of the SNS, AANS, and CNS, and as Secretary of the Neurosurgical Society of America, and is an ABNS Examiner. Dr. Huang was elected to the editorial board of the Journal of Neurosurgery in 2019.

 

Anthony M. Kaufmann, MD

Dr. Kaufmann received his MD, BSc (Medicine), and MSc (Surgery) from the University of Manitoba, where he also completed his neurosurgery residency. He then joined the Department of Neurological Surgery at the University of Pittsburgh Medical Center (1994–1997) before returning to Canada, at the University of Calgary (1997–2000) and then the University of Manitoba (2001–present). In addition to specialization in cerebrovascular and cranial base microneurosurgery, he is Director of both the Winnipeg Centres for Cranial Nerve Disorders and GammaKnife Surgery, as a well as Supervisor of the Intra-Operative Monitoring Program.

Dr. Kaufmann is board certified by both the Royal College of Physicians and Surgeons of Canada (1994) and the American Board of Neurosurgical Surgeons (2017). He served on the Neurosurgery Examination Committee for the Royal College of Physicians and Surgeons of Canada (2013–2017). Dr. Kaufmann was elected to the editorial board of the Journal of Neurosurgery in 2019.

 

Gabriel Zada, MD

Dr. Gabriel Zada is an Associate Professor of Neurosurgery, Otolaryngology, and Internal Medicine at the Keck School of Medicine of USC. He attended UC Berkeley for his undergraduate studies and medical school at UC San Francisco. He then went on to complete his residency at USC, under the mentorship of Dr. Martin Weiss and Dr. Steven Giannotta. He completed a fellowship in endoscopic pituitary and skull base surgery at Brigham and Women’s Hospital with Dr. Edward Laws. He joined the USC faculty in 2011 and currently serves as Director of the USC Endoscopic Skull Base Surgery Program, Co-Director of the USC Pituitary Center, and Co-Director of the USC Stereotactic Radiosurgery Program. He is the Associate Program Director of the USC Neurosurgery Residency Program.

Dr. Zada has a keen clinical and academic interest in brain and skull base tumor surgery and has published more than 150 peer-reviewed articles on various topics, mostly relating to brain/pituitary tumors, skull base surgery, neuroendoscopy, simulation-based education, and stereotactic radiosurgery. He coauthored and edited the textbook entitled The Atlas of Sellar and Parasellar Lesions. He is an independent NIH-funded principal investigator, whose research laboratory at the USC Zilkha Neurogenetic Institute focuses on the genomics and epigenetics of pituitary tumors and meningiomas. Dr. Zada also serves on the editorial board of Neurosurgery and the Journal of Neuro-Oncology. Dr. Zada was elected to the editorial board of the Journal of Neurosurgery in 2019.

 

Manish Aghi

Manish Aghi, MD, PhD, is a Professor and Vice Chair of Neurosurgery at the University of California, San Francisco (UCSF). He attended Stanford University for his undergraduate studies and completed MD-PhD degrees at Harvard University. He then went on to complete his residency at Massachusetts General Hospital. He joined the UCSF faculty in 2008 and currently serves as Director of the Center for Minimally Invasive Skull Base Surgery, Head of the Education Division and Clerkship Director in the Department of Neurosurgery, and a Principal Investigator in the Brain Tumor Research Center. Dr. Aghi runs a basic science laboratory studying the brain tumor microenvironment that has been continuously NIH funded since joining the UCSF faculty. He has published nearly 200 peer-reviewed basic science and clinical articles focused on brain tumors. He was elected to the American Academy of Neurological Surgery in 2016 and served as Chair of the American Association of Neurological Surgeons/Congress of Neurological Surgeons (AANS/CNS) Joint Section on Tumors from 2018 to 2020. Dr. Aghi also serves on the editorial board of Neurosurgery and the Journal of Neuro-Oncology. Dr. Aghi was elected to the editorial board of the Journal of Neurosurgery in 2020.

 

Andrew Carlson

Andrew Carlson, MD, MS-CR, is a faculty neurosurgeon at the University of New Mexico. Born in Los Alamos, New Mexico, Dr. Carlson trained at the University of New Mexico and did fellowships in endovascular neurosurgery at the University of Illinois–Chicago and skull base/vascular at the University of South Florida, ultimately returning to practice in the only tertiary care center for neurosurgery in New Mexico. He is the Director of Research in Neurosurgery and Director of Cerebrovascular and Neurointerventional Surgery. He is the Co-Director of the New Mexico Spreading Depolarization Consortium. Nationally, Dr. Carlson is an active reviewer for the Joint Guidelines Review Committee and also serves on the multispecialty American Board of Psychiatry and Neurology (ABPN) Neurocritical Care Examination Writing Committee. He has published many peer-reviewed articles and is centrally involved in multiple clinical trials. He is NIH funded for clinical research focused on secondary brain injury and spreading depolarizations. Dr. Carlson was elected to the editorial board of the Journal of Neurosurgery in 2020.

 

Elizabeth B. Claus

Elizabeth B. Claus, MD, PhD, is a Professor and Director of Medical Research in the Yale University School of Public Health as well as Attending Neurosurgeon and Director of Stereotactic Radiosurgery within the Department of Neurosurgery at Brigham and Women’s Hospital in Boston, Massachusetts. She received her undergraduate degree from Wellesley College, a master’s degree in mathematics from the University of Virginia, and her MD-PhD from Yale University. Dr. Claus trained as a neurosurgeon at Yale–New Haven Hospital and completed a fellowship in neurosurgical oncology at Brigham and Women’s Hospital. She is a member of the Council of Medical Advisors for the American Brain Tumor Association (ABTA) as well as the Central Brain Tumor Registry of the United States (CBTRUS). Dr. Claus’ research is focused on cancer and genetic epidemiology with an emphasis on the development of risk models for breast and brain tumors. She is the overall Principal Investigator of the Meningioma Consortium, the Meningioma Genome-Wide Association Study, and the Yale Acoustic Neuroma Study as well as a co-investigator of the GLIOGENE (Genes for Glioma) and International Glioma Case/Control (GICC) projects. In partnership with national patient brain tumor organizations including the ABTA, the Acoustic Neuroma Association (ANA), and the National Brain Tumor Society (NBTS), Dr. Claus is working to develop cost- and time-efficient web-based recruitment strategies to be used in the study of brain tumors, including the Yale Acoustic Neuroma Study and the International Low Grade Glioma Registry. Dr. Claus was elected to the editorial board of the Journal of Neurosurgery in 2020.

 

William Mack

William Mack, MD, is a Professor of Neurosurgery, Vice Chair of Academic Affairs, and a faculty member of the Neuroscience Graduate Program at University of Southern California. His area of clinical focus is endovascular and open surgical management of patients with cerebrovascular disease. Dr. Mack received his bachelor’s degree with honors from Cornell University. He then attended Columbia University, College of Physicians and Surgeons, where he graduated from medical school and completed neurosurgical residency training. Following residency, Dr. Mack completed an Interventional Neuroradiology fellowship at UCLA. Dr. Mack is the Principal Investigator and Director of the Cerebrovascular Laboratory in the Zilkha Neurogenetic Institute. His overarching academic goal is to examine the effects of inflammation/air pollution in experimental models of cerebrovascular disease. Dr. Mack is the Principal Investigator on active NIH (NINDS, NIA, and NIEHS) grants. He also serves as an Associate Editor of the Journal of Neurointerventional Surgery and an Editorial Board member for World Neurosurgery. Dr. Mack serves on the Board of Directors of the Society of Neurointerventional Surgery and Executive Committee of the Joint Cerebrovascular Section of the Congress of Neurological Surgeons/American Association of Neurological Surgeons. Dr. Mack was elected to the editorial board of the Journal of Neurosurgery in 2020.

 

Daniel M. Prevedello

Daniel M. Prevedello, MD, is currently Professor of Neurosurgery and Otolaryngology–Head and Neck Surgery, Co-Director of the Comprehensive Skull Base and Pituitary Surgery Center and Director of the Minimally Invasive Cranial Surgery Program at The Ohio State University, Wexner Medical Center and Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. Dr. Prevedello is also Co-Director of the Anatomy Laboratory Toward Visuospatial Surgical Innovations in Otolaryngology and Neurosurgery (ALT-VISION) at The Ohio State University. Dr. Prevedello attended medical school at the Universidade Federal do Parana in Curitiba, Brazil, where he also completed his neurological surgery residency at the Hospital Nossa Senhora das Graças. He completed a fellowship in neuroendocrine and pituitary surgery at the University of Virginia and another in skull base and cerebrovascular surgery at the University of Pittsburgh. In 2008 Dr. Prevedello joined the Faculty at the University of Pittsburgh as Assistant Professor and was named Director of the Skull Base Surgery Training Program. In 2010 he moved to The Ohio State University, where he became Associated Professor in 2012. As the Director of the Minimally Invasive Cranial Surgery Program and Co-Director of the Comprehensive Skull Base and Pituitary Surgery, Dr. Prevedello was promoted to Professor with Tenure of The Ohio State University in 2017. Dr. Prevedello has a particular clinical and academic interest in brain and skull base tumor surgery and has published more than 250 peer-reviewed articles on various topics mostly related to brain and skull base tumors, skull base reconstruction, neuroendoscopy, and novel techniques and technologies. Dr. Prevedello also serves on the editorial boards of Operative Neurosurgery, World Neurosurgery, and Frontiers in Neurology/Oncology. Dr. Prevedello was elected to the editorial board of the Journal of Neurosurgery in 2020.

 

Bernard R. Bendok

Dr. Bernard R. Bendok is the Chair of the Department of Neurosurgery at Mayo Clinic in Arizona and the William J. and Charles H. Mayo Professor of Neurosurgery, Radiology, and Otolaryngology in the Mayo Clinic Alix School of Medicine. He also serves as the neurosurgery residency director at Mayo Clinic in Arizona and the Director of the Cerebrovascular Endovascular and Skull Base Fellowship. His practice is focused on cerebrovascular diseases, skull base diseases, and brain tumors. His research is focused on simulation science, device innovation, and clinical trials. Dr. Bendok was elected to the Editorial Board of the Journal of Neurosurgery in 2021.

 

Kate Drummond

Dr. Kate Drummond is the Director of Neurosurgery at Royal Melbourne Hospital and Head of CNS Tumors at the VCCC Parkville Precinct. Her research and clinical interests are in the biology and management of brain tumors. She has published over 140 peer-reviewed articles and received more than $15 million in research funding. She is Co-Editor-in-Chief of the Journal of Clinical Neuroscience and immediate past Chief Examiner in Neurosurgery for the Royal Australasian College of Surgeons. She is the Chair of Pangea Global Health Education, a for-impact organization specializing in health education in low-resource settings. In 2019, she was awarded Member of the Order of Australia (AM) for services to medicine, particularly in neuro-oncology. Dr. Drummond was elected to the Editorial Board of the Journal of Neurosurgery in 2021.

 

Constantinos Hadjipanayis

Dr. Constantinos Hadjipanayis is a Professor of Neurosurgery and Oncological Sciences at the Icahn School of Medicine at Mount Sinai. He serves as the Chair of the Department of Neurosurgery at Mount Sinai Union Square/Beth Israel and Director of Neurosurgical Oncology for the Mount Sinai Health System in New York City. He is the Director of the Mount Sinai Brain Tumor Nanotechnology Laboratory, where he studies novel therapeutics targeting brain tumors. His graduate work at the University of Pittsburgh, during his neurosurgery residency, focused on viral gene therapy of brain cancer. He led the development of 5-ALA (Gleolan) and fluorescence-guided surgery (FGS) for malignant brain tumors in the US that resulted in FDA approval in 2017. Dr. Hadjipanayis was elected to the Editorial Board of the Journal of Neurosurgery in 2021.

 

David Hasan

Dr. David Hasan is currently a Professor of Neurosurgery, Otolaryngology, and Biomedical Engineering. He completed his medical school training at Texas Tech University with AOA distinction, followed by residency training at the University of Iowa. During his residency he won the prestigious Dandy Walker followship award and spent his 5th year of residency training with Dr. Almefty in skull base surgery. He then went on to finish several fellowships, including diagnostic angiography with Lee Jessen, endovascular with Robert Rosenwasser, and open cerebrovascular with Juha Hernesniemi.

Dr. Hasan is a scientist-neurosurgeon with continuous NIH funding for the last 10 years and currently holds three R01s. He also serves as an assistant editor for Stroke, associate editor for Neurosurgery, and served on several NIH study section review committees. He has authored over 250 peer-reviewed PubMed publications. Dr. Hasan was elected to the Editorial Board of the Journal of Neurosurgery in 2021.

 

Peter Kan

Dr. Peter Kan is the Professor and Robert L. Moody Sr. Chair of the Department of Neurosurgery at the University of Texas Medical Branch. He pursued neurosurgical training and a Master of Public Health at the University of Utah. He then went on to an endovascular fellowship at the University at Buffalo. Upon the completion of his fellowship, he joined the faculty at the University of South Florida and was subsequently recruited to Baylor College of Medicine as the Director of Cerebrovascular Surgery. His research interests include novel neuroendovascular devices, intravascular imaging, and intra-arterial cell-based therapy for malignant brain tumors. Dr. Kan was elected to the Editorial Board of the Journal of Neurosurgery in 2021.

 

Nader Sanai

Dr. Nader Sanai is the J. N. Harber Professor of Neurological Surgery at the Barrow Neurological Institute (BNI). He completed medical school and residency at UCSF, followed by a skull-base surgery fellowship at BNI. As Director of Neurosurgical Oncology, his practice is devoted to patients with benign and malignant brain tumors, particularly those in high-risk areas. He was elected to the American Academy of Neurological Surgeons in 2016 and, in 2018, he founded the Ivy Brain Tumor Center, a nonprofit, early-phase drug development program for brain cancer. His NIH-funded laboratory and clinical research efforts have led to over 150 peer-reviewed publications and 100 national and international lectures in neuro-oncology. Dr. Sanai was elected to the Editorial Board of the Journal of Neurosurgery in 2021.

 

Alon MogilnerAlon Mogilner

Dr. Mogilner is an Associate Professor of Neurosurgery and Anesthesiology at NYU Grossman School of Medicine and the Director of the Center for Neuromodulation at NYU Langone Health. He received his MD and PhD degrees in neuroscience at the NYU School of Medicine and completed his residency in neurosurgery and fellowship in Functional Neurosurgery at NYU Medical Center. He is past president of the AANS/CNS Section on Pain and served as a board member of the American Society for Stereotactic and Functional Neurosurgery for 8 years. He specializes in the use of neuromodulation and lesioning techniques, including deep brain stimulation and focused ultrasound. Dr. Mogilner was elected to the Editorial Board of the Journal of Neurosurgery in 2022.

 

Dario J. EnglotDario J. Englot

Dario J. Englot, MD, PhD, is a tenured Associate Professor of Neurological Surgery, Neurology, Radiology, Electrical Engineering, and Biomedical Engineering at Vanderbilt University. He is also Director of Functional Neurosurgery and Surgical Director of Epilepsy at Vanderbilt University Medical Center, and director of a CAST-accredited fellowship in Functional Neurosurgery. He received his MD and PhD degrees from Yale University and completed neurosurgical residency at the University of California, San Francisco, and his functional neurosurgery fellowship at Vanderbilt University. Dr. Englot leads an active translational research laboratory integrating human neuroimaging and electrophysiology techniques to study brain networks in neurological diseases and normal brain states. He serves on the board of the American Society for Stereotactic and Functional Neurosurgery and he is chair of the Surgical Therapies Commission in the International League Against Epilepsy. He is also a Fellow of the American Epilepsy Society and serves on the editorial boards of Epilepsy Currents and Epilepsy & Behavior. Dr. Englot was elected to the Editorial Board of the Journal of Neurosurgery in 2022.

 

Ian F. ParneyIan F. Parney

Dr. Ian F. Parney is Professor and Vice-Chair of the Department of Neurological Surgery, and Neurosurgical Oncology Fellowship Program Director at the Mayo Clinic in Rochester, Minnesota. Born and raised in Calgary, Alberta, Canada, he attended college at McGill University. After receiving his MD and PhD degrees and completing his neurosurgical residency at the University of Alberta, Dr. Parney completed neuro-oncology training at the University of California, San Francisco, with Dr. Mitch Berger. His clinical and research interests focus on brain tumor surgery and immunotherapy. He is currently the Co-Director of the National Coordination Center for the Glioblastoma Therapeutics Network, an NCI-sponsored cooperative group. Dr. Parney was elected to the Editorial Board of the Journal of Neurosurgery in 2022.

 

Juan Fernandez-Miranda

Dr. Juan Fernandez-Miranda is Professor of Neurosurgery and Chief of Skull Base and Pituitary Surgery at Stanford University Medical Center. He completed neurosurgery residency at La Paz University Hospital in Madrid, Spain. Upon completion of his residency, he was awarded the Sanitas Prize to the best medical postgraduate trainee in the country. From 2005 to 2007, he underwent research fellowship training in microsurgical neuroanatomy at University of Florida under legendary neurosurgeon Albert L. Rhoton Jr. From 2007 to 2010 he continued subspecialty clinical training in cerebrovascular surgery at University of Virginia and endoscopic endonasal and open skull base surgery at University of Pittsburgh Medical Center (UPMC). In 2018, after a 10-year tenure at UPMC, Dr. Fernandez-Miranda was recruited to lead the Stanford Skull Base and Pituitary Center and the Stanford Neurosurgical Training and Innovation Center. Dr. Fernandez-Miranda has authored more than 200 peer-reviewed publications with multiple innovative contributions to the fields of endoscopic endonasal skull base and pituitary surgeries, microsurgical neuroanatomy, white matter dissection and tractography, surgical approaches, and techniques. He is co-founder and vice-president of the International Rhoton Society and executive member of the Board of Directors of The Neurosurgical Atlas. Dr. Fernandez-Miranda serves on the editorial boards of Operative Neurosurgery and Journal of Neurological Surgery-Skull Base. Dr. Fernandez-Miranda was elected to the Editorial Board of the Journal of Neurosurgery in 2022.

 

Michael LimMichael Lim

Dr. Michael Lim is Professor and Chair of Neurosurgery at Stanford University. Dr. Lim obtained his MD degree from The Johns Hopkins University School of Medicine. He then completed his residency in Neurosurgery at Stanford University Hospital. Dr. Lim’s surgical interest is brain tumors and trigeminal neuralgia.

Dr. Lim’s research interest is developing immune-based therapies against brain tumors. In addition to understanding the mechanisms of immune evasion by primary brain tumors, findings from his laboratory are directed toward translation to novel therapies against brain tumors. He also serves as the principal investigator of several large brain tumor immunotherapy clinical trials based on findings from his laboratory. Dr. Lim was elected to the Editorial Board of the Journal of Neurosurgery in 2022.

 

Phil TausskyPhil Taussky

Dr. Phil Taussky serves as the Co-Director of the Brain Aneurysm Institute and Surgical Co-Director of the Comprehensive Stroke Center at Beth Israel Deaconess Medical Center in Boston. After receiving his MD degree at the University of Basel, Switzerland, Dr. Taussky completed a neurosurgery residency at the Kantonsspital Aarau, the largest county hospital in Switzerland, which is known for its busy neurosurgery service and its strong cerebrovascular and trauma service. Dr. Taussky then completed a skull base/cerebrovascular fellowship at the University of Utah and an endovascular fellowship at the Mayo Clinic. He was then recruited to the University of Utah where he served as section Chief of Neurovascular Surgery until 2022. Dr. Taussky’s practice is focused on the surgical and endovascular treatment of cerebrovascular disorders of the brain and spinal cord. He has a particular interest in the treatment of intracranial aneurysms and arteriovenous malformations of the brain and spinal cord using novel techniques and devices and a secondary interest in the treatment of skull base tumors. His research interests include novel endovascular devices, management of acute stroke, and complication analysis and prevention. Dr. Taussky was elected to the Editorial Board of the Journal of Neurosurgery in 2022.

 

Stacey Quintero WolfeStacey Quintero Wolfe

Stacey Quintero Wolfe, MD, FAANS, is a Professor of Neurological Surgery and Radiology at Wake Forest School of Medicine. She trained in Neuroendovascular and Cerebrovascular/Skull Base Surgery at the University of Miami and served as Lieutenant Commander in the U.S. Navy before joining Wake Forest School of Medicine, where she is Residency Program Director and Director of Neurointerventional Surgery. Dr. Wolfe is site co-PI of NINDS StrokeNet and has a translational lab investigating neuroinflammation and genomics surrounding hemorrhagic stroke. Dr. Wolfe serves on the AANS Board of Directors and the SNS Executive Council. She has served as Chair of Women in Neurosurgery, Young Neurosurgeons Committee, and the Joint Guidelines Committee. Dr. Wolfe was elected to the Editorial Board of the Journal of Neurosurgery in 2022.

 

Sunit DasSunit Das

Sunit Das is an Associate Professor of Neurosurgery at the University of Toronto and currently serves as the Provincial Lead for CNS Oncology at Cancer Care Ontario. He studied English Literature at the University of Michigan and Philosophy at Harvard University before completing medical school at Northwestern University and doctoral studies in Neurobiology at the National Institutes of Health. Dr. Das’s clinical practice is focused on the care of patients with benign and malignant brain tumors. His laboratory focuses on the molecular and genetic mechanisms that regulate tumor evolution and treatment resistance in glioblastoma. Dr. Das was elected to the Editorial Board of the Journal of Neurosurgery in 2022.